
Sign up to save your podcasts
Or


This episode explores a layer of pharmacology that quietly shapes almost every therapeutic decision but is often overlooked: membrane transporters. These proteins act as biological customs officers, controlling drug entry, distribution, and elimination at the cellular level. We examine how transporters influence variability in drug response, underpin many drug–drug interactions, and explain why two patients with the same dose can have very different outcomes.
Key takeaways you’ll build and reuse throughout the series:
* Transporters as active participants, not passive plumbing: uptake and efflux systems that shape exposure at target organs.
* Key families and patterns: where major transporter systems are located (gut, liver, kidney, brain) and why location matters more than memorising names.
* Transporters and variability: genetic differences, disease states, and developmental factors that alter drug handling.
* Drug–drug interactions revisited: competition, inhibition, and saturation at transporter “checkpoints.”
* Clinical relevance: recognising when transporters explain unexpected toxicity, therapeutic failure, or non-linear dosing behaviour.
By Med School Audio - Medical Knowledge Reimagined & Learning Made Memorable.This episode explores a layer of pharmacology that quietly shapes almost every therapeutic decision but is often overlooked: membrane transporters. These proteins act as biological customs officers, controlling drug entry, distribution, and elimination at the cellular level. We examine how transporters influence variability in drug response, underpin many drug–drug interactions, and explain why two patients with the same dose can have very different outcomes.
Key takeaways you’ll build and reuse throughout the series:
* Transporters as active participants, not passive plumbing: uptake and efflux systems that shape exposure at target organs.
* Key families and patterns: where major transporter systems are located (gut, liver, kidney, brain) and why location matters more than memorising names.
* Transporters and variability: genetic differences, disease states, and developmental factors that alter drug handling.
* Drug–drug interactions revisited: competition, inhibition, and saturation at transporter “checkpoints.”
* Clinical relevance: recognising when transporters explain unexpected toxicity, therapeutic failure, or non-linear dosing behaviour.